The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1707 RELEVANCE OF CIRCADIAN DISRUPTION AND<br />
CIRCADIAN INDUCTION FOR CANCER CONTROL.<br />
F. Levi. Rhythmes Biologiques et Cancer, INSERM, Villejuif, France. Sponsor: H. Zarbl.<br />
<strong>The</strong> circadian timing system drives daily changes in xenobiotic metabolism and<br />
detoxification, cell cycle events, DNA repair, apoptosis, and angiogenesis. As a result<br />
the main hallmarks <strong>of</strong> cancer, including inflammation, are under circadian<br />
control. Cancer promotion and/or progression are accelerated in rodents with circadian<br />
disruption resulting from ablation <strong>of</strong> the suprachiasmatic nuclei, the central<br />
pacemaker; chronic jet lag; or clock gene mutation. Circadian disruption is also involved<br />
in chemical carcinogenesis. Cancer patients with circadian disruption display<br />
poor survival, as compared with those with robust circadian rhythms, despite<br />
similar clinical characteristics. Clock genes are down-regulated in most experimental<br />
and human cancers and impairment <strong>of</strong> tumor molecular clocks can accelerate<br />
cancer growth. Circadian induction in tumor tissue with defective circadian clocks<br />
using timed seliciclib or meals slows tumor growth in mice. Meal timing induces<br />
the rhythmic expression <strong>of</strong> over 400 genes for tumor growth in a pancreatic tumor.<br />
We show that the circadian amplitude <strong>of</strong> core body temperature is critical for circadian<br />
induction in tumor and implicates cell stress signaling pathways in tumor<br />
transcriptome entrainment. Circadian timing can also modify the tolerability and<br />
efficacy <strong>of</strong> anticancer drugs in patients. Improved efficacy correlates with the respective<br />
times <strong>of</strong> best tolerability, due to (a) inherently poor circadian entrainment<br />
<strong>of</strong> tumors and (b) persistent circadian entrainment <strong>of</strong> healthy tissues. Conversely,<br />
host clocks are disrupted whenever anticancer drugs are administered at their most<br />
toxic time, while speeding cancer processes. Mathematical and systems biology approaches<br />
currently develop and integrate theoretical, experimental, and technological<br />
tools in order to further optimize and personalize the circadian administration<br />
<strong>of</strong> cancer treatments. <strong>The</strong> detection <strong>of</strong> early warning signals (temperature and restactivity)<br />
may provide relevant decision making information for the personalization<br />
<strong>of</strong> cancer chronotherapeutics.<br />
1708 METHYLSELENOCYSTEINE RESETS THE RHYTHMIC<br />
EXPRESSION OF CIRCADIAN AND GROWTH<br />
REGULATORY GENES DISRUPTED BY<br />
NITROSOMETHYLUREA IN VIVO.<br />
M. Fang and H. Zarbl. Environmental and Occupational Health Sciences Institiute,<br />
Robert Wood Johnson Medical School, Piscataway, NJ.<br />
<strong>The</strong> role <strong>of</strong> Selenium (Se) in chemoprevention <strong>of</strong> mammary carcinomas was first<br />
suggested by animal studies performed by Ip and coworkers who showed that feeding<br />
carcinogen-treated rats garlic grown in selenium enriched soil, dramatic reduced<br />
tumor incidence. Subsequent studies demonstrated that methylselenocysteine<br />
(MSC), the active form <strong>of</strong> Se, mediates its effects at the post-initiation stage <strong>of</strong><br />
carcinogenesis. However, the in vivo mechanisms <strong>of</strong> MSC-mediated chemoprevention<br />
are still poorly understood at the molecular level. To investigate how a dietary<br />
MSC is able to reduce the incidence <strong>of</strong> mammary carcinoma in pubescent female<br />
Fischer 344 (F344) rats exposed to N’-nitoso-N’-methyurea (NMU), we used<br />
DNA microarrays and qPCR to compare gene expression pr<strong>of</strong>iles in mammary tissue<br />
<strong>of</strong> NMU-treated F344 rats fed a MSC-enriched diet (3 ppm Se) to that <strong>of</strong> rats<br />
on a standardized diet (0.1 ppm Se). Unexpectedly, the most dramatic effect <strong>of</strong> dietary<br />
MSC supplementation was on the genes involved in the network <strong>of</strong> circadian<br />
rhythm, providing the first evidence for the link between circadian rhythm and<br />
chemoprevention. Exposure to a single carcinogenic dose <strong>of</strong> the alkylating agent,<br />
NMU, resulted in a persistent disruption in the rhythmic expression <strong>of</strong> several circadian<br />
genes, including Period 2 (Per2), Rev-ErbA α, the Melatonin Receptor 1α<br />
(MTNR1A), as well as estrogen receptor beta (ERβ), in contrast, dietary MSC significantly<br />
restored or enhanced the circadian expression <strong>of</strong> these genes during the<br />
early stage <strong>of</strong> mammary tumoregenesis. At meantime, dietary MSC also promotes<br />
circadian expression <strong>of</strong> genes essential to normal mammary cell growth and differentiation<br />
(ER[|#61472#|]b, Trp53, p21, Gadd45[|#61537#|]), suggesting an important<br />
role <strong>of</strong> enhanced-circadian rhythm on inhibition <strong>of</strong> tumoregenesis.<br />
Analysis <strong>of</strong> tumors that arising in animals fed a MSC-enriched diet showed that<br />
these tumors lost MSC-induced expression <strong>of</strong> circadian genes compared to normal<br />
mammary glands, indicating that circadian gene expression was incompatible with<br />
NMU-induced mammary carcinogenesis.<br />
1709 MACROPHAGES: REGULATORS OF TOXICITY AND<br />
DISEASE PATHOGENESIS.<br />
D. Laskin and A. Gow. Pharmacology and <strong>Toxicology</strong>, Rutgers University,<br />
Piscataway, NJ.<br />
Macrophages function as control switches <strong>of</strong> the immune system, providing a balance<br />
between pro- and anti-inflammatory responses. To accomplish this, they develop<br />
into different subsets: classically (M1) or alternatively (M2) activated<br />
368 SOT 2011 ANNUAL MEETING<br />
macrophages. Whereas M1 macrophages display a cytotoxic, proinflammatory phenotype,<br />
M2 macrophages, suppress immune and inflammatory responses and participate<br />
in wound repair and angiogenesis. Critical to the actions <strong>of</strong> these divergent<br />
or polarized macrophage subpopulations is the regulated release <strong>of</strong> inflammatory<br />
mediators. When properly controlled, classically activated M1 macrophages effectively<br />
destroy invading pathogens, tumor cells, and foreign materials. However,<br />
when M1 activation becomes uncontrolled, these cells release excessive quantities <strong>of</strong><br />
cytotoxic mediators that contribute to disease pathogenesis. <strong>The</strong> activity <strong>of</strong> M1<br />
macrophages is countered by alternatively activated M2 macrophages which release<br />
mediators that down regulate M1 cells, and stimulate growth, extracellular matrix<br />
turnover, and tissue repair. Aberrant functioning <strong>of</strong> M2 macrophages can lead to fibrosis<br />
and tumor metastasis and progression. Ultimately, it is the balance in the<br />
production <strong>of</strong> mediators by these two cell types that determines the outcome <strong>of</strong> the<br />
tissue response to chemical toxicants and disease progression. <strong>The</strong>se different models<br />
will be presented to illustrate this divergent role <strong>of</strong> macrophages in disease<br />
pathogenesis and toxicity.<br />
1710 MACROPHAGES AND HEPATOTOXICITY: A BATTLE<br />
OF FORCES.<br />
D. Laskin 1 , C. Gardner 1 ,Y. Liu 1 and J. Laskin 2 . 1 Pharmacology and <strong>Toxicology</strong>,<br />
Rutgers University, Piscataway, NJ and 2 UMDNJ-RWJ Medical School, Piscataway, NJ.<br />
Accumulating evidence suggests that macrophages are key in acetaminophen<br />
(APAP) hepatotoxicity. However, their role in the pathogenic process depends on<br />
the timing <strong>of</strong> their appearance in the liver, and the inflammatory mediators they<br />
encounter which direct their functional responses. Initially, macrophages responding<br />
to stimuli such as LPS, HMGB1 and/or TNFα release proinflammatory cytokines<br />
and cytotoxic mediators contributing to toxicity. Later in the pathogenic<br />
process, following exposure to IL-10 or IL-4/IL-13, they function to down regulate<br />
inflammation and initiate wound repair. <strong>The</strong>se activities appear to be mediated by<br />
distinct subpopulations <strong>of</strong> macrophages exhibiting a classically (M1) or alternatively<br />
(M2) activated phenotype. This is supported by findings that APAP intoxication<br />
results in early accumulation <strong>of</strong> macrophages in the liver expressing M1 markers<br />
(e.g., TNFα, inducible nitric oxide synthase) followed by cells expressing M2<br />
markers (e.g., arginase, galectin). Additionally, the appearance <strong>of</strong> M1 and M2<br />
macrophage subpopulations correlates with evidence <strong>of</strong> oxidative stress and liver injury<br />
(reduced GSH, elevated serum transaminases) and tissue repair (hepatocyte<br />
proliferation, expression <strong>of</strong> the growth factors, CTGF and TGFβ), respectively. It<br />
appears that the switch in macrophage phenotype from M1 to M2 is a consequence<br />
<strong>of</strong> a changing cytokine environment. This is consistent with findings that the M2<br />
chemokines and macrophage activators, MCP-1/CCR-2, IL-10 and IL-4/IL-13,<br />
are upregulated in the liver during the initial stages <strong>of</strong> APAP-induced tissue repair.<br />
Whereas pretreatment <strong>of</strong> animals with gadolinium chloride, an M1 inhibitor, protects<br />
against APAP induced hepatotoxicity, clodronate liposomes, which suppress<br />
M2 cells, exacerbates tissue injury. <strong>The</strong>se data demonstrate that macrophages with<br />
distinct phenotypes play different roles in APAP hepatotoxicity; moreover the outcome<br />
<strong>of</strong> the response depends on the balance between these cell populations (NIH<br />
GM034310, ES005022 AR055073, ES004738, CA132624).<br />
1711 LUNG MACROPHAGE RESPONSES TO BIOACTIVE<br />
ENGINEERED NANOMATERIALS (ENM) INVOLVES<br />
ACTIVATION OF THE NLRP3 INFLAMMASOME.<br />
A. Holian and C. Migliaccio. Center for Environmental Health Sciences, University<br />
<strong>of</strong> Montana, Missoula, MT.<br />
Exposure to ENM can lead to lung inflammation and fibrosis. <strong>The</strong> mechanisms<br />
underlying the development <strong>of</strong> these pathologies, and the characteristics that separate<br />
bioactive from benign ENM have not been established. Evidence suggests that<br />
cells <strong>of</strong> the innate immune system initiate and sustain chronic inflammation required<br />
for the development <strong>of</strong> pulmonary fibrosis. Alveolar and interstitial<br />
macrophages are the primary innate immune cells in the lung; subpopulations <strong>of</strong><br />
these cells have been implicated in the development <strong>of</strong> chronic inflammation and<br />
fibrosis. A key pathway in the macrophage initiation <strong>of</strong> inflammation is the NLRP3<br />
inflammasome. Activation <strong>of</strong> the NLRP3 inflammasome results in activated caspase-1<br />
and cleavage <strong>of</strong> the pro-IL-1β family <strong>of</strong> cytokines into bioactive forms.<br />
Excessive and sustained productions <strong>of</strong> IL-1β, and possibly IL-18, appear to be responsible<br />
for chronic inflammation. Utilizing C57Bl/6 and Balb/c strains <strong>of</strong> mice,<br />
we evaluated the responses <strong>of</strong> a series <strong>of</strong> well-characterized multi-walled carbon<br />
nanotubes and titanium dioxide ENM by using in vitro (isolated AM) and in vivo<br />
systems. Our studies demonstrate that bioactive (causing lung inflammation and<br />
pathology) ENM consistently induce activation <strong>of</strong> the NLRP3 inflammasome by<br />
classically activated macrophages. In contrast, benign ENM cause little or no activation<br />
<strong>of</strong> the NLRP3 inflammasome. <strong>The</strong> results indicate that inflammasome activation<br />
can be predicted by shape and composition. Thus, long durable ENM and